Our focus this year is on eliminating viral hepatitis.READ MORE
Helping women, children and their families
make informed and powerful decisions about
Bringing together experts from all over the world
to improve maternal and child health
Harnessing the body’s response to HIV and antiretrovirals
to improve treatment and quality of life
Ensuring effective treatments are available for common infections
for generations to come
Generating scientific information necessary to market drugs
at doses that are safe and effective for children
Standardizing best practices across disease areas
and populations to improve paediatric infectious disease research
Paving the way to better healthcare
and better lives.
This finding from the REALITY trial was published yesterday in the New England Journal of Medicine.READ MORE
The PENTA-ID Network brings together key stakeholders in paediatric infectious disease, including researchers, clinicians, regulatory bodies, the pharmaceutical industry and patients and their families, to plan and carry out high quality clinical research and training. The network began in 1991 as PENTA, the Paediatric European Network for Treatment of AIDS, and focused on conducting clinical trials on antiretroviral therapy among HIV-infected children. It later integrated with the European Collaborative Study, one of the largest cohorts of children born to HIV-positive mothers.
In 2011 the network officially became PENTA-ID (Infectious Diseases), expanding and applying its expertise in HIV to other paediatric infectious diseases. The network now spans over 90 clinical sites in 18 countries, providing the access to paediatric patients necessary to perform clinical research, and leverages the expertise and experience in paediatric infectious disease of hundreds of participating researchers and physicians. In addition to coordinating and participating in trials and cohort studies, the network develops treatment guidelines and training programmes for health care professionals on various aspects of prevention and treatment of paediatric infectious disease, and contributes to European and global efforts to improve research infrastructure and harmonize and streamline research methods.